Stanley Laman Group, Ltd. Pfizer Inc Transaction History

Stanley Laman Group, Ltd.

$529 Million
Q1 2025

A detailed history of Stanley Laman Group, Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Stanley Laman Group, Ltd. holds 14,000 shares of PFE stock, worth $326,900. This represents 0.07% of its overall portfolio holdings.

Number of Shares

14,000

Previous 19,922 29.73%

Holding current value

$326,900

Previous $528,000 32.95%

% of portfolio

0.07%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	SELL	$25.01 - $27.13 $148,109 - $160,663	-5,922 Reduced 29.73%	14,000 $354,000
Q4 2024 Jan 29, 2025	SELL	$24.8 - $30.19 $764,608 - $930,787	-30,831 Reduced 60.75%	19,922 $528,000
Q3 2024 Oct 21, 2024	SELL	$27.7 - $31.39 $46,452 - $52,641	-1,677 Reduced 3.2%	50,753 $1.47 Million
Q2 2024 Jul 18, 2024	BUY	$25.26 - $29.6 $50,520 - $59,200	2,000 Added 3.97%	52,430 $1.47 Million
Q1 2024 Apr 17, 2024	SELL	$25.89 - $29.73 $133,825 - $153,674	-5,169 Reduced 9.3%	50,430 $1.4 Million
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $1.17 Million - $1.52 Million	44,722 Added 411.16%	55,599 $1.6 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $392,877 - $454,549	10,877 New	10,877 $398,000
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $2.91 Million - $3.28 Million	-86,814 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $136,758 - $173,900	4,086 Added 4.94%	86,814 $3.2 Million
Q3 2020 Oct 20, 2020	BUY	$31.75 - $37.25 $93,249 - $109,403	2,937 Added 3.68%	82,728 $3.04 Million
Q2 2020 Jul 20, 2020	BUY	$30.12 - $36.54 $105,630 - $128,145	3,507 Added 4.6%	79,791 $2.61 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $25,218 - $36,032	933 Added 1.24%	76,284 $2.49 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $122,758 - $139,315	-3,729 Reduced 4.72%	75,351 $2.95 Million
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $89,932 - $116,615	-2,768 Reduced 3.38%	79,080 $2.84 Million
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $4,844 - $5,439	-131 Reduced 0.16%	81,848 $3.55 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $7,237 - $7,951	-193 Reduced 0.23%	81,979 $3.48 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $296,142 - $337,634	-7,698 Reduced 8.57%	82,172 $3.59 Million
Q3 2018 Oct 30, 2018	SELL	$34.47 - $41.81 $38,985 - $47,287	-1,131 Reduced 1.24%	89,870 $3.96 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $165,196 - $176,116	-5,009 Reduced 5.22%	91,001 $3.3 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $95,570 - $110,874	-2,995 Reduced 3.03%	96,010 $3.41 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $5,687 - $6,034	-171 Reduced 0.17%	99,005 $3.59 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $3.07 Million - $3.39 Million	99,176	99,176 $3.54 Million

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stanley Laman Group, Ltd. with notifications on news.

Account

Stanley Laman Group, Ltd. Pfizer Inc Transaction History